![N-{2-methyl-5'-(morpholin-4-yl)-6'-[(oxan-4-yl)oxy][3,3'-bipyridin]-5-yl}-3-(trifluoromethyl)benzamide in PDB entry 5vam, assembly 1, side view.](https://www.ebi.ac.uk/pdbe/static/entry/5vam_entity_2_side_image-200x200.png "Monomeric assembly 1 of PDB entry <span class='highlight'>5vam</span> contains 1 copy of <span class='highlight'>N-{2-methyl-5'-(morpholin-4-yl)-6'-[(oxan-4-yl)oxy][3,3'-bipyridin]-5-yl}-3-(trifluoromethyl)benzamide</span>. Side view.")
![N-{2-methyl-5'-(morpholin-4-yl)-6'-[(oxan-4-yl)oxy][3,3'-bipyridin]-5-yl}-3-(trifluoromethyl)benzamide in PDB entry 5vam, assembly 1, top view.](https://www.ebi.ac.uk/pdbe/static/entry/5vam_entity_2_top_image-200x200.png "Monomeric assembly 1 of PDB entry <span class='highlight'>5vam</span> contains 1 copy of <span class='highlight'>N-{2-methyl-5'-(morpholin-4-yl)-6'-[(oxan-4-yl)oxy][3,3'-bipyridin]-5-yl}-3-(trifluoromethyl)benzamide</span>. Top view.")
Environment details NEW
92J 801 bound to chain A
The above 2D and 3D (Mol*) views of ligand interactions use quaternary structure derived from the PDB entry.
Please note:
Please note:
- Some chain IDs in the tooltip are followed by a number in square brackets. This number corresponds to the operation ID (mmCIF ‘oper_expression’) used to transform the chain.
- The structure seen in Mol* (3D view) was protonated using ChimeraX.
- Interactions were calculated using Arpeggio (see details for interaction types).
- The colour scheme used is consistent with Clustal X.